eslicarbazepine acetate
PolandDrugs containing this active substance
-
The medicine is used in the treatment of epilepsy to reduce the number of seizures. In adults with newly diagnosed epilepsy, it is used as monotherapy, whereas in adults, adolescents, and children over 6 years of age, it may be used as an adjunct to other anti-epileptic drugs.
Form: tablets
Active substance Dosage eslicarbazepine acetate 200 mg ATC: N03AF04
Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH
-
The medicine is used to treat epilepsy to reduce the number of seizures. In adults, it may be used as monotherapy, whereas in adults, adolescents, and children over 6 years of age, it may be used as adjunctive therapy for partial seizures.
Form: tablets
Active substance Dosage eslicarbazepine acetate 400 mg ATC: N03AF04
Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH
-
The medicine is used in the treatment of epilepsy in adults (as monotherapy) and in adults, adolescents, and children over 6 years of age (as adjunctive treatment for partial seizures). Its purpose is to reduce the number of epileptic seizures.
Form: tablets
Active substance Dosage eslicarbazepine acetate 600 mg ATC: N03AF04
Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH
-
The medicinal product is used in the treatment of epilepsy in adults (as monotherapy) and in adults, adolescents, and children over 6 years of age (as adjunctive treatment for partial seizures). It is intended to reduce the number of seizures.
Form: tablets
Active substance Dosage eslicarbazepine acetate 800 mg ATC: N03AF04
Manufacturer: Delorbis Pharmaceuticals Ltd., G.L. Pharma GmbH